Please login to the form below
Healthcare terms - T
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare terms - T
- Tactical planning
- Tagging
- Target audience
- Target publications
- Tariffs
- Technical efficiency (pharmacoeconomics)
- Telesales
- Terms and conditions of purchase
- Terms and conditions of sale
- Territory
- Territory management
- Test marketing
- Testimonials
- Therapy area
- Tonal bias
- Tone of the media
- Top-of-mind awareness (TOMA)
- Toxicity
- Trade advertising
- Trade allowance
- Trade barriers
- Trade publications
- Trademark
- Transfer price
- Treatment Investigational New Drug (IND)
- Treatment trials
- Treatment trials
- Trend analysis
- Trial endpoint
- Trial stage
Featured jobs
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
-
Senior Medical Writer
-
Salary TBC
-
Events Executive
-
DOE
-
Senior Copywriter
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
-
Account Director, Medical Education
-
Salary TBC
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Competitive salary plus benefits
Subscribe to our email news alerts
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- GSK forms cell therapy R&D pact with star-studded biotech
- UCB gets bigger in rare diseases with $2.1bn purchase of Ra Pharma
- Gilead builds case for Descovy PrEP after FDA approval
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- J&J hit by $8bn judgment for man claiming breast growth due to Risperdal
- The era of digital wellbeing
- Increased discount leads NICE to reverse positon on Clovis cancer drug
- Looking after the mental health of the Porterhouse family
- Bayer opens AI-enabled drug discovery center in UK
- In a U-turn, ICER takes more positive view of AbbVie’s Rinvoq
- Roche’s MabThera beats incumbent drug in pemphigus vulgaris phase 3
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Quick links
Infographics
